Top Bush Health Adviser Stands to Gain Personally from Candidate's Medicare
Plan

Gail Wilensky holds shares and options in health care companies valued at
$10.5 million; another Bush adviser, lobbyist Deborah Steelman, collected
$6.5 million in fees from health care special interests

The prescription drug and Medicare reform proposal recently unveiled by
Republican presidential candidate George W. Bush was shaped by Gail R.
Wilensky, a senior adviser (1) who has a substantial financial interest in
the enactment of such a program. Wilensky – who is Bush's leading
spokesperson on Medicare issues – holds shares and stock options currently
valued at $10.5 million in the managed care, insurance, nursing home and
drug industries that could benefit handsomely from the Bush plan... SNIP

http://www.citizen.org/congress/reform/drug_industry/contribution/articles.cfm?ID=5260